LFVN logo

LFVN LifeVantage Corporation

NASDAQ Capital Market · Packaged Foods · Consumer Defensive

$4.15
-0.74 (-15.13%)

LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions,…

Market Cap: $52.63Mwww.lifevantage.com

Price

No data yet.

Social Signal Score

58
5d
—
30d
60
4 mentions
—
60d
55
6 mentions
—
90d
58
10 mentions
—
news: 10

Analyst Ratings

3 analysts
Holdconsensus
Strong Buy 0Buy 1Hold 2Sell 0Strong Sell 0
Avg price target$7+68.7%
Low $6Median $7High $8
Current Consensus

Revenue

$37.12M-24.17%
$37.12M$47.33M$57.55M$67.76M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.81
$0.79–$0.83
1 analysts
FY2026
$0.56-31% YoY
$0.55–$0.57
1 analysts
FY2027
$0.26-54% YoY
$0.26–$0.27
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Terrence Moorehead
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
216
Beta
0.73
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
2.20
www.lifevantage.com